Impact of Netrin-1 in the Pathophysiology of Placenta Accreta Spectrum

NCT04628169 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2024-09-20

No results posted yet for this study

Summary

The main goal of this study is to assess the role of Netrin 1, neogenin and ZEB1 in PAS-associated invasion

Conditions

  • Pathophysiology of Placenta Accreta

Interventions

OTHER

no intervention applied

no intervention applied

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Eligibility

Min Age
20 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-01-01
Primary Completion
2023-01-01
Completion
2023-07-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04628169 on ClinicalTrials.gov